External Advisory Board
The Ohio State University Center for Clinical and Translational Science
External Advisory Board Members
Marcia Stefanik, PhD, Professor of Medicine (Stanford Prevention Research Center, SPRC), and Professor of Obstetrics and Gynecology, is Co-Director of the new Stanford Center for Health Research on Women and Sex Differences, Stanford University School of Medicine, where she co-leads the Stanford Cancer Institute’s Cancer Prevention and Control Program and the Sanford Cardiovasucular Institute’s Women’s Heart Health program.
Stefanick’s research focuses on chronic disease prevention, e.g. heart disease, breast and other cancers, osteoporosis, and dementia, and aging in both women and men and her work on the effects of menopausal hormones in predominantly healthy postmenopausal women (the Women’s Health Initiative, WHI, hormone trials), women with established heart disease, (the Heart and Estrogen-progesterone Replacement Study, HERS), and peri-menopausal and early post-menopausal women (the Postmenopausal Estrogen and Progesterone Interventions, PEPI, trial) has been widely disseminated, nationally and internationally.
She was also principal investigator of two large multi-center diet trials of a low-fat eating pattern (including increased vegetables & fruits) for preventing breast cancer (WHI) and recurrence (Women’s Healthy Eating and Living, WHEL, trial) and she has conducted several medium-sized diet, exercise, and weight control trials that have influenced national guidelines.
Other EAB Members:
Andrew M. Dahlem, PhD, was named vice president and chief operating officer for Lilly Research Laboratories (LRL) and LRL Europe in February 2007. He has previously served as vice president of toxicology, drug disposition, pharmacokinetics, and Lilly Research Laboratories in Europe since January 2003 and is a member of Lilly senior management.
Dahlem received a bachelor of science degree in wildlife biology from The Ohio State University in 1982 and a doctor of philosophy degree in toxicology from the University of Illinois at Urbana-Champaign in 1989. He joined Lilly in 1990 as a senior pharmacologist and became head of biochemical toxicology in 1992. He was named director of drug disposition and biochemical (investigative) toxicology in 1993. Dahlem was promoted to executive director for toxicology and drug disposition in 1998, and he assumed responsibility for LRL in Europe in 1999 and for discovery operations in 2000, and in 2001 promoted to Vice President.
Dahlem serves as adjunct professor of toxicology in the College of Veterinary Medicine at Purdue University, the University of Illinois at Urbana-Champaign, and at The Ohio State University. He is also a member of the Ohio State University College of Pharmacy Corporate Council and the Illinois Professional Science Master’s Board.
Dahlem currently serves on the board of directors for Indigo Biosystems, the YourEncore board of advisors, and is a member of the Indiana State Museum Foundation Board of Directors. He is a member of the Institute of Medicine Forum on Drug Discovery, Development and Translation, and the Translational Research and the Critical Path for Tuberculosis Drug Regimens for the Gates Foundation.
Philip Greenland, MD, is the Harry W. Dingman Professor of Preventive Medicine and Medicine, Northwestern University Feinberg School of Medicine. His research, teaching, and clinical interests focus on the prevention of cardiovascular diseases.
Greenland has authored over 300 papers, book chapters, and monographs on topics related to heart disease prevention, heart disease in women, risk prediction, and other aspects of heart disease. From 2004-2008, Greenland was Chief Editor of Archives of Internal Medicine. He is a member of the NHLBI Board of External Experts, of the NHLBI's Observational Study Monitoring Board for the Framingham Heart Study, and a recent standing member of the NIH Study Section on Cardiovascular and Sleep Epidemiology (CASE).
Greenland is an Honorary Fellow of the Royal College of Physicians of London, elected in 2008. He was, from 2005-2012, the Senior Associate Dean for Clinical and Translational Research at the Northwestern University Feinberg School of Medicine and Director of the Northwestern University Clinical and Translational Sciences Institute. He was also Principal Investigator of Northwestern University's Clinical and Translational Science Award (CTSA) from 2007-2012.
Johnson’s research explores the use of information systems to promote communication, coordination and collaboration in patient care and biomedical research. The goal is to develop models that increase our understanding of interactions between information systems and biomedical organizational structures, patterns of work flow, and the specialized languages that professionals employ. This work is a fusion between technical and social disciplines, drawing from computer science, information technology, cognition, linguistics, and behavioral and organizational science.
Methods include database design, natural language processing, distributional linguistic analysis, work flow analysis and social network analysis. Applications include electronic health records, research databases, clinical research systems and systems to locate scientific expertise, resources and collaboration.
Kurt Kroenke, MD, is Professor of Medicine in the Division of General Internal Medicine and Geriatrics at Indiana University, and a Research Scientist in the Regenstrief Institute. He is a past President of the Society of General Internal Medicine and Immediate Past-President of the Association for Clinical Research Training.
Kroenke has served on the National Institutes of Mental Health (NIMH) Services Research Study Section, the MacArthur Foundation Steering Committee on Depression in Primary Care, and several Institute of Medicine committees. His research focuses on physical and psychological symptoms in medical patients including pain, depression, anxiety and somatization.
Kroenke has been a principal or co-investigator on multiple effectiveness trials for depression and more recently pain, including several NIH-funded studies. He has more than 200 peer-reviewed publications.
Doris M. Rubio, PhD, is a Professor of Medicine, Biostatistics, Nursing, and Clinical and Translational Science at the University of Pittsburgh. She directs the Evaluation Core in the Clinical and Translational Science Institute (CTSI) and codirects the Education Core.
Rubio is the past Director of the Design, Biostatistics, and Epidemiology Core for the CTSI. Additionally, she is the Co-Director of the Institute for Clinical Research Education, which provides training in clinical and translational research and offers multiple programs for career development. She is Director of the Center for Research on Health Care Data Center, which provides data management and analysis services across the University.
Nationally, Rubio serves multiple leadership roles. She is the Past President for the Association for Clinical Research Training and is the Chair for the Evaluation Key Function Committee for the Clinical and Translational Science Awards. Her research focuses on alcohol use co-occurring with depression in women and in particular how life events impact alcohol use and depression. She has published in such fields as psychometrics, structural equation modeling, quality of life indicators, alcoholism, and career development.
Lisa Guay-Woodford, MD, is the Richard L. Hudson Professor of Pediatrics and the Associate Vice President for Clinical and Translational Research at The George Washington University. She also serves as Director of the Center for Translational Science at Children’s National Medical Center (CNMC) and Director of the Clinical and Translational Science Institute-Children’s National (CTSI-CN).
Guay-Woodford is a Pediatric Nephrologist and an internationally-recognized investigator whose research focuses on identifying clinical and genetic factors involved in the pathogenesis of inherited renal disorders, most notably autosomal recessive polycystic kidney disease.
In April 2012, she moved to CNMC from the University of Alabama at Birmingham, where she had founded and served as Director of the Inherited Renal Disorders Program at the Children's Hospital of Alabama, established the NIH P30-funded UAB HepatoRenal Fibrocystic Disease Research and Translational Core Center (HRFDCC) and was the founding Director of the UAB Center for Clinical and Translational Science.